Anal cancer is a disease in which malignant (cancer) cells form in the tissues of the anus. Being infected with the human papillomavirus (HPV) increases the risk of developing anal cancer. Signs of anal cancer include bleeding from the anus or rectum or a lump near the anus.
The Global Anal Cancer Market is estimated to be valued at USD 810.7 million in 2021 and is expected to exhibit a compound annual growth rate (CAGR) of 6.6% from 2021-2028.
This report studies the Anal Cancer market size (value and volume) by players, regions, product types and end industries, history data 2017-2020 and forecast data 2021-2028; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Anal Cancer in these regions, from 2017 to 2028, covering
The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in this market include
We can also provide the customized separate regional or country-level reports, for the following regions:
The study objectives of this report are:
In this study, the years considered to estimate the market size of Anal Cancer are as follows:
History Year: 2017-2020
Base Year: 2020
Estimated Year: 2020
Forecast Year 2021 to 2028
This report includes the estimation of market size for value (million USD) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Anal Cancer market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Available Customizations
With the given market data, EternityInsights offers customizations according to the company's specific needs. The following customization options are available for the report:
Further breakdown of Anal Cancer market on basis of the key contributing countries. Detailed analysis and profiling of additional market players.
Table of Contents
1 Anal Cancer Market Overview
1.1 Anal Cancer Product Overview
1.2 Anal Cancer Market Segment by Type
1.2.1 Fluorouracil
1.2.2 Cisplatin
1.2.3 Carboplatin
1.2.4 Other
1.3 Global Anal Cancer Market Size by Type
1.3.1 Global Anal Cancer Sales and Growth by Type
1.3.2 Global Anal Cancer Sales and Market Share by Type (2017-2020)
1.3.3 Global Anal Cancer Revenue and Market Share by Type (2017-2020)
1.3.4 Global Anal Cancer Price by Type (2017-2020)
2 Global Anal Cancer Market Competition by Company
2.1 Global Anal Cancer Sales and Market Share by Company (2017-2020)
2.2 Global Anal Cancer Revenue and Share by Company (2017-2020)
2.3 Global Anal Cancer Price by Company (2017-2020)
2.4 Global Top Players Anal Cancer Manufacturing Base Distribution, Sales Area, Product Types
2.5 Anal Cancer Market Competitive Situation and Trends
2.5.1 Anal Cancer Market Concentration Rate
2.5.2 Global Anal Cancer Market Share of Top 5 and Top 10 Players
2.5.3 Mergers & Acquisitions, Expansion
3 Anal Cancer Company Profiles and Sales Data
3.1 GlaxoSmithKline
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 Anal Cancer Product Category, Application and Specification
3.1.3 GlaxoSmithKline Anal Cancer Sales, Revenue, Price and Gross Margin(2017-2020)
3.1.4 Main Business Overview
3.2 Spectrum Pharmaceuticals
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 Anal Cancer Product Category, Application and Specification
3.2.3 Spectrum Pharmaceuticals Anal Cancer Sales, Revenue, Price and Gross Margin(2017-2020)
3.2.4 Main Business Overview
3.3 Hospira
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 Anal Cancer Product Category, Application and Specification
3.3.3 Hospira Anal Cancer Sales, Revenue, Price and Gross Margin(2017-2020)
3.3.4 Main Business Overview
3.4 Global BioPharma
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 Anal Cancer Product Category, Application and Specification
3.4.3 Global BioPharma Anal Cancer Sales, Revenue, Price and Gross Margin(2017-2020)
3.4.4 Main Business Overview
3.5 Advaxis
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 Anal Cancer Product Category, Application and Specification
3.5.3 Advaxis Anal Cancer Sales, Revenue, Price and Gross Margin(2017-2020)
3.5.4 Main Business Overview
3.6 Amgen Inc
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 Anal Cancer Product Category, Application and Specification
3.6.3 Amgen Inc Anal Cancer Sales, Revenue, Price and Gross Margin(2017-2020)
3.6.4 Main Business Overview
3.7 Atara Biotherapeutics
3.7.1 Company Basic Information, Manufacturing Base and Competitors
3.7.2 Anal Cancer Product Category, Application and Specification
3.7.3 Atara Biotherapeutics Anal Cancer Sales, Revenue, Price and Gross Margin(2017-2020)
3.7.4 Main Business Overview
3.8 Bayer
3.8.1 Company Basic Information, Manufacturing Base and Competitors
3.8.2 Anal Cancer Product Category, Application and Specification
3.8.3 Bayer Anal Cancer Sales, Revenue, Price and Gross Margin(2017-2020)
3.8.4 Main Business Overview
3.9 Cell Medica
3.9.1 Company Basic Information, Manufacturing Base and Competitors
3.9.2 Anal Cancer Product Category, Application and Specification
3.9.3 Cell Medica Anal Cancer Sales, Revenue, Price and Gross Margin(2017-2020)
3.9.4 Main Business Overview
3.10 Eli Lilly
3.10.1 Company Basic Information, Manufacturing Base and Competitors
3.10.2 Anal Cancer Product Category, Application and Specification
3.10.3 Eli Lilly Anal Cancer Sales, Revenue, Price and Gross Margin(2017-2020)
3.10.4 Main Business Overview
3.11 Genticel
3.12 ISA Pharmaceuticals
3.13 Merck?Co
3.14 Millennium Pharmaceuticals
3.15 Novartis
3.16 ??Ono Pharmaceutical
3.17 Oryx
3.18 PDS Biotechnology
3.19 Sun Pharma
4 Anal Cancer Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global Anal Cancer Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.2 Global Anal Cancer Sales and Revenue by Regions
4.2.1 Global Anal Cancer Sales and Market Share by Regions (2017-2020)
4.2.2 Global Anal Cancer Revenue and Market Share by Regions (2017-2020)
4.2.3 Global Anal Cancer Sales, Revenue, Price and Gross Margin (2017-2020)
4.3 North America Anal Cancer Sales, Revenue, Price and Gross Margin
4.3.1 United States
4.3.2 Canada
4.3.3 Mexico
4.4 Europe Anal Cancer Sales, Revenue, Price and Gross Margin
4.4.1 Germany
4.4.2 UK
4.4.3 France
4.4.4 Italy
4.4.5 Russia
4.4.6 Turkey
4.5 Asia-Pacific Anal Cancer Sales, Revenue, Price and Gross Margin
4.5.1 China
4.5.2 Japan
4.5.3 Korea
4.5.4 Southeast Asia
4.5.4.1 Indonesia
4.5.4.2 Thailand
4.5.4.3 Malaysia
4.5.4.4 Philippines
4.5.4.5 Vietnam
4.5.5 India
4.5.6 Australia
4.6 South America Anal Cancer Sales, Revenue, Price and Gross Margin
4.6.1 Brazil
4.7 Middle East and Africa Anal Cancer Sales, Revenue, Price and Gross Margin
4.7.1 Egypt
4.7.2 GCC Countries
5 Anal Cancer Application/End Users
5.1 Anal Cancer Segment by Application
5.1.1 Hospitals
5.1.2 Long-term care centers
5.1.3 Pharmacies
5.1.4 Other
5.2 Global Anal Cancer Product Segment by Application
5.2.1 Global Anal Cancer Sales by Application
5.2.2 Global Anal Cancer Sales and Market Share by Application (2017-2020)
6 Global Anal Cancer Market Forecast
6.1 Global Anal Cancer Sales, Revenue Forecast (2021-2028)
6.1.1 Global Anal Cancer Sales and Growth Rate Forecast (2021-2028)
6.1.1 Global Anal Cancer Revenue and Growth Rate Forecast (2021-2028)
6.2 Global Anal Cancer Forecast by Regions
6.2.1 North America Anal Cancer Sales and Revenue Forecast (2021-2028)
6.2.2 Europe Anal Cancer Sales and Revenue Forecast (2021-2028)
6.2.3 Asia-Pacific Anal Cancer Sales and Revenue Forecast (2021-2028)
6.2.3.1 China
6.2.3.2 Japan
6.2.3.3 Korea
6.2.3.4 Southeast Asia
6.2.3.5 India
6.2.3.6 Australia
6.2.4 South America Anal Cancer Sales and Revenue Forecast (2021-2028)
6.2.5 Middle East and Africa Anal Cancer Sales and Revenue Forecast (2021-2028)
6.2.5.1 Egypt
6.2.5.2 GCC Countries
6.3 Anal Cancer Forecast by Type
6.3.1 Global Anal Cancer Sales and Revenue Forecast by Type (2021-2028)
6.3.2 Fluorouracil Gowth Forecast
6.3.3 Cisplatin Gowth Forecast
6.4 Anal Cancer Forecast by Application
6.4.1 Global Anal Cancer Sales Forecast by Application (2021-2028)
6.4.2 Global Anal Cancer Forecast in Hospitals
6.4.3 Global Anal Cancer Forecast in Long-term care centers
7 Anal Cancer Upstream Raw Materials
7.1 Anal Cancer Key Raw Materials
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price
7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Anal Cancer Industrial Chain Analysis
8 Marketing Strategy Analysis, Distributors
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Distributors
8.3 Downstream Customers
9 Research Findings and Conclusion
Appendix
Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
Data Source
Secondary Sources
Primary Sources
Disclaimer
Choose License Type